Hypha Labs Launches Mushroom Accelerator™ for Faster Production

LAS VEGAS, NV, October 5, 2026 /CourierPR/ -- Hypha Labs, Inc., a company developing innovative biomanufacturing technologies, has announced a groundbreaking platform that aims to revolutionize the production of mushroom-derived active ingredients. The new Mushroom Accelerator™ platform promises to significantly reduce production time and costs, potentially changing the economics of the rapidly growing functional mushroom industry.

According to Hypha Labs, the Mushroom Accelerator™ can produce mushroom-derived biological material in just eight days, compared to the conventional 90-day cultivation process. This accelerated production timeline is expected to bring substantial benefits to manufacturers, including improved batch consistency and reduced labor requirements. The company claims that its platform could achieve operational and production cost savings of up to 80% through automation, a smaller production footprint, and minimized biological waste.

Hypha Labs' platform utilizes proprietary Micropearls™ as biological starting material for downstream extraction and formulation of mushroom-derived active ingredients. These ingredients are used in a variety of applications, including nutraceuticals, supplements, functional beverages, and research applications. The company's objective is to create a repeatable supply platform for manufacturers seeking consistent mushroom-derived ingredients.

The global functional mushroom market is projected to experience significant growth, reaching $42.27 billion in 2026 and expanding to $95.95 billion by 2033, according to Grand View Research. Hypha Labs aims to capitalize on this growth by providing a more efficient and cost-effective production method for mushroom-derived active ingredients.

By combining accelerated production with substantial potential cost reductions, Hypha Labs hopes to address a critical challenge within the expanding functional mushroom industry. The company's platform is designed to improve scalability, consistency, and manufacturing efficiency, making it a valuable tool for manufacturers in the rapidly growing market.

Hypha Labs, Inc. (OTCQB:FUNI) is developing proprietary automated mushroom production technologies to support the growth of the functional mushroom industry. The company's forward-looking statements, as described in its filings with the U.S. Securities and Exchange Commission, acknowledge that actual results may differ due to various risks and uncertainties.